Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00983645 · ClinicalTrials.gov registry record · Phase 4

A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity

A Phase 4 study, sponsored by Loma Linda University.

Terminated
Registry status
Phase 4
Development phase
15
Enrollment target

NCT00983645: Clinical Trial Phase 4 study, sponsored by Loma Linda University.

NCT00983645 is a Phase 4 study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 15 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00983645, a Phase 4 study, was terminated before completion, sponsored by Loma Linda University.

TERMINATED
Registry status
Phase 4
Development phase
15 participants
Enrollment target

Study Summary

This study aims to compare outcomes in renal transplant recipients in the hispanic population based on their immunosuppressant regimens.

Interventions

  • DRUG Prograf
  • DRUG Neoral

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2004-10
Est. Completion 2013-03
Phase Phase 4
Loma Linda University

237 total trials

Why NCT00983645 stopped before completion

NCT00983645 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Prograf is the first listed.

NCT00983645 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00983645 about?

NCT00983645 is a clinical study titled "A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity". This study aims to compare outcomes in renal transplant recipients in the hispanic population based on their immunosuppressant regimens.

What is the current status of trial NCT00983645?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2004-10. Estimated completion is 2013-03.

What interventions are being tested in trial NCT00983645?

The interventions under investigation include: Prograf (DRUG), Neoral (DRUG).

Who is sponsoring clinical trial NCT00983645?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00983645's enrollment target sits among peer trials

15 1880th of 2000 higher than 100 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00983645, the US trial registry maintained by the National Library of Medicine. NCT00983645 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.